NCT05975905: A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study).

Sponsor: Keros Therapeutics, Inc.. Phase: PHASE2. Conditions: Pulmonary Arterial Hypertension